Connie Trinacty, PhD

Biography

Connie Trinacty, PhD, is a health services and policy researcher whose work investigates the complex dynamics among health systems, patients, providers, and chronic care disparities. Her research focuses on the impact of health system and policy changes on access to equitable, quality health services and outcomes for vulnerable and diverse patient populations, with particular interest in understanding how to improve patient adherence to self-management practices, leading to better clinical and patient-centered outcomes.

Before joining CHR, Dr. Trinacty was an assistant professor in the Department of Population Medicine at the Harvard Medical School and Harvard Pilgrim Health Care Institute. Her studies applied longitudinal methods based on large claims data to identify the challenges patients faced with adhering to recommended diabetes medications and blood glucose self-monitoring, and assessed the extent to which these challenges impacted racial/ethnic subgroups.

Her current research places strong emphasis on building partnerships with health system leaders and patient advisors to evaluate natural experiments in health care.  She is the principal investigator on an NIDDK-funded R18 that examines whether a real-world, value-based insurance design program, offering zero copay for all diabetes-related medications and supplies, improves self-care practices and clinical control while reducing disparities in diabetes care.

Dr. Trinacty earned her doctorate in health policy with a concentration in evaluative science and statistics from Harvard University and completed a fellowship in pharmaceutical policy research at Harvard Medical School. She received a master’s degree in health policy and management from the Harvard T.H. Chan School of Public Health, and an undergraduate degree in psychology from Amherst College.

Selected Publications

 
  • Juarez DT, Williams AE, Chen C, Daida YG, Tanaka SK, et al. Factors affecting medication adherence trajectories for patients with heart failure. Am J Manag Care. 2015 Mar 1;21(3):e197-205. PubMed PMID: 26014307.
  • Adams AS, Soumerai SB, Zhang F, Gilden D, Burns M, Huskamp H, Trinacty C, Alegria M, LeCates RF, Griggs J, Ross-Degnan D, Maden JM. The effect of removing drug coverage caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.  Clinical Therapeutics, 37(3): 597-609. Epub 2015 Jan 22.
  • Wharam JF, Soumerai S, Trinacty C, Eggleston E, Zhang F, et al. Impact of emerging health insurance arrangements on diabetes outcomes and disparities: rationale and study design. Prev Chronic Dis. 2013;10:E11. PubMed PMID: 23369764; PubMed Central PMCID: PMC3562172.
  • Simon SR, Trinacty CM, Soumerai SB, Piette JD, Meigs JB, et al. Improving diabetes care among patients overdue for recommended testing: a randomized controlled trial of automated telephone outreach. Diabetes Care. 2010 Jul;33(7):1452-3. PubMed PMID: 20357376; PubMed Central PMCID: PMC2890338.
  • Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009 Feb 7;9:24. PubMed PMID: 19200387; PubMed Central PMCID: PMC2645384.
  • Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, et al. Racial differences in long-term self-monitoring practice among newly drug-treated diabetes patients in an HMO. J Gen Intern Med. 2007 Nov;22(11):1506-13. PubMed PMID: 17763913; PubMed Central PMCID: PMC2219792.
  • Mah CA, Soumerai SB, Adams AS, Ross-Degnan D. Racial differences in impact of coverage on diabetes self-monitoring in a health maintenance organization. Med Care. 2006 May;44(5):392-7. PubMed PMID: 16641656.
  • Soumerai SB, Mah C, Zhang F, Adams A, Barton M, et al. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med. 2004 Mar 22;164(6):645-52. PubMed PMID: 15037493.